{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T02:17:42Z","timestamp":1695262662196},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transactions of the Royal Society of Tropical Medicine and Hygiene"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.trstmh.2008.08.015","type":"journal-article","created":{"date-parts":[[2008,10,3]],"date-time":"2008-10-03T08:31:24Z","timestamp":1223022684000},"page":"613-619","source":"Crossref","is-referenced-by-count":9,"title":["Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir\/abacavir"],"prefix":"10.1093","volume":"103","author":[{"given":"Johan","family":"van Griensven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rony","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freya","family":"Rasschaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edi F.","family":"Att\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.trstmh.2008.08.015_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected patients","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trstmh.2008.08.015_bib2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.qai.0000229996.75116.da","article-title":"Fat distribution in women with HIV infection","volume":"42","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.trstmh.2008.08.015_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/QAI.0b013e318162f597","article-title":"Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women","volume":"47","author":"Justman","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.trstmh.2008.08.015_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1086\/507333","article-title":"Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy","volume":"43","author":"Wohl","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trstmh.2008.08.015_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/135965350701200508","article-title":"Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral treatment in a large South African cohort","volume":"12","author":"Boulle","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.trstmh.2008.08.015_bib6","doi-asserted-by":"crossref","first-page":"S449","DOI":"10.1086\/521112","article-title":"Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary","volume":"196","author":"Murphy","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.trstmh.2008.08.015_bib7","unstructured":"WHO. Report on WHO\/UNAIDS meeting on forecasting ARV needs up to 2010. 7\u20138 November 2005. Geneva: World Health Organization; 2005. www.who.int\/hiv\/amds\/ReportForecastingMeeting.pdf [accessed 21 July 2008]."},{"key":"10.1016\/j.trstmh.2008.08.015_bib8","unstructured":"WHO. Antiretroviral treatment for HIV infection in adults and adolescents in resource-limited settings: towards universal access. Recommendations for a public health approach. 2006 Revision. Geneva: World Health Organization; 2006. http:\/\/www.who.int\/hiv\/pub\/guidelines\/adult\/en\/index.html [accessed 21 July 2008]"},{"key":"10.1016\/j.trstmh.2008.08.015_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.trstmh.2008.08.015_bib10","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"27","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.trstmh.2008.08.015_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","article-title":"Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy","volume":"17","author":"Mallon","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.trstmh.2008.08.015_bib12","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/QAD.0b013e328270356a","article-title":"Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy","volume":"21","author":"Brown","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.trstmh.2008.08.015_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.qai.0000248353.56125.43","article-title":"Relation of stavudine discontinuation to anthropometric changes among HIV-infected women","volume":"44","author":"Tien","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.trstmh.2008.08.015_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.trstmh.2007.02.020","article-title":"High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda","volume":"101","author":"van Griensven","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.trstmh.2008.08.015_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/380790","article-title":"Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study","volume":"38","author":"McComsey","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trstmh.2008.08.015_bib16","unstructured":"M\u00e9decins Sans Fronti\u00e8res. Antiretroviral therapy in primary healthcare: Scaling-up in two health centres in Kigali, Rwanda. Brussels: M\u00e9decins Sans Fronti\u00e8res; 2007. http:\/\/www.msf.org\/source\/countries\/africa\/rwanda\/2007\/MSF_Rwanda%20capitalisation_final.pdf [accessed 21 July 2008]"},{"key":"10.1016\/j.trstmh.2008.08.015_bib17","first-page":"6","article-title":"Nutrition assessment in HIV infection","volume":"8","author":"Gerrior","year":"2005","journal-title":"Nutr Clin Care"},{"key":"10.1016\/j.trstmh.2008.08.015_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/521150","article-title":"Adverse effects of highly active antiretroviral therapy in developing countries","volume":"15","author":"Subbaraman","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trstmh.2008.08.015_bib19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","article-title":"An objective case definition in HIV-infected adults: a case-control study","volume":"361","author":"Carr","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.trstmh.2008.08.015_bib20","unstructured":"McComsey G, Riordan M, Storer N, Goldman S, Ganz J, Libutti D, et al. Clinical lipoatrophy assessment strongly correlates with DEXA-measured limb fat and subcutaneous fat mitochondrial DNA levels. In: 13th Conference on Retroviruses and Opportunistic Infections; 5-8 February 2006; Denver. Abstract 751. http:\/\/www.retroconference.org\/2006\/Abstracts\/26736.HTM [accessed 21 July 2008]."},{"key":"10.1016\/j.trstmh.2008.08.015_bib21","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.trstmh.2008.08.015_bib22","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1097\/01.aids.0000247574.33998.03","article-title":"A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy","volume":"20","author":"Moyle","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.trstmh.2008.08.015_bib23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/500398","article-title":"Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort","volume":"42","author":"Mangili","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trstmh.2008.08.015_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0035-9203(96)90123-6","article-title":"Nutritional status and weight gain in patients with pulmonary tuberculosis in Tanzania","volume":"90","author":"Kennedy","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.trstmh.2008.08.015_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.aids.0000196177.65551.ea","article-title":"Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya","volume":"20","author":"Wools-Kaloustiana","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.trstmh.2008.08.015_bib26","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/jac\/dkn097","article-title":"Changes in metabolic toxicity after switching from stavudine\/didanosine to tenofovir\/lamivudine--a Staccato trial substudy","volume":"61","author":"Ananworanich","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.trstmh.2008.08.015_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-6405-4-19","article-title":"Assessment of quality of life in HAART-treated HIV-positive subjects with body fat redistribution in Rwanda","volume":"4","author":"Mutimura","year":"2007","journal-title":"AIDS Res Ther"}],"container-title":["Transactions of the Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/103\/6\/613\/5449548\/103-6-613.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T06:26:13Z","timestamp":1684563973000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article-lookup\/doi\/10.1016\/j.trstmh.2008.08.015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0035920308003544"],"URL":"https:\/\/doi.org\/10.1016\/j.trstmh.2008.08.015","relation":{},"ISSN":["0035-9203"],"issn-type":[{"value":"0035-9203","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}